Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The MedStar Georgetown Headache Center is a specialized clinical facility within MedStar Georgetown University Hospital dedicated to the comprehensive diagnosis and management of complex headache disorders. The center employs a multidisciplinary approach, offering patients access to advanced pharmacological treatments, interventional procedures, and lifestyle-based therapies. It is particularly recognized for its expertise in administering CGRP-targeted monoclonal antibodies, botulinum toxin injections, and various neuromodulation devices. As an academic-affiliated center, it integrates high-level clinical care with research and education, frequently serving as a site for clinical trials evaluating emerging headache therapies. The center provides personalized care plans for conditions ranging from chronic migraine and cluster headaches to rare secondary headache syndromes. Its affiliation with the Georgetown University School of Medicine ensures that patients receive care informed by the latest neurological research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedStar Georgetown Headache Center.